Year |
Citation |
Score |
2019 |
Goel A, Nishikawa K, Futaya E, Poylak I, Holt R, Li M, Sagastum E, Marks B, Bossler AD, Johnson FL, Schultz MK, Goda H, Okada H, Orcutt K, Abe G, et al. Abstract LB-230: Quantitative immunohistochemistry for melanocortin 1 receptor using phosphor integrated dots Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-230 |
0.354 |
|
2018 |
Banerjee S, Ji C, Mayfield JE, Goel A, Xiao J, Dixon JE, Guo X. Ancient drug curcumin impedes 26S proteasome activity by direct inhibition of dual-specificity tyrosine-regulated kinase 2. Proceedings of the National Academy of Sciences of the United States of America. PMID 29987021 DOI: 10.1073/Pnas.1806797115 |
0.383 |
|
2016 |
Schibler J, Tomanek-Chalkley AM, Reedy JL, Zhan F, Spitz DR, Schultz MK, Goel A. Mitochondrial-Targeted Decyl-Triphenylphosphonium Enhances 2-Deoxy-D-Glucose Mediated Oxidative Stress and Clonogenic Killing of Multiple Myeloma Cells. Plos One. 11: e0167323. PMID 27902770 DOI: 10.1371/Journal.Pone.0167323 |
0.445 |
|
2015 |
Salem K, McCormick ML, Wendlandt E, Zhan F, Goel A. Copper-zinc superoxide dismutase-mediated redox regulation of bortezomib resistance in multiple myeloma. Redox Biology. 4: 23-33. PMID 25485927 DOI: 10.1016/J.Redox.2014.11.002 |
0.646 |
|
2014 |
Salem K, McCormick ML, Wendlandt E, Zhan F, Goel A. Copper-Zinc Superoxide Dismutase as a Target for Enhancing Bortezomib Cytotoxicity in Multiple Myeloma Free Radical Biology and Medicine. 76: S130-S131. DOI: 10.1016/J.Freeradbiomed.2014.10.208 |
0.58 |
|
2013 |
Brown CO, Schibler J, Fitzgerald MP, Singh N, Salem K, Zhan F, Goel A. Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma. Leukemia Research. 37: 963-9. PMID 23537707 DOI: 10.1016/J.Leukres.2013.03.004 |
0.659 |
|
2013 |
Salem K, Brown CO, Schibler J, Goel A. Combination chemotherapy increases cytotoxicity of multiple myeloma cells by modification of nuclear factor (NF)-κB activity. Experimental Hematology. 41: 209-18. PMID 23063726 DOI: 10.1016/J.Exphem.2012.10.002 |
0.667 |
|
2012 |
Jung JJ, Tiwari A, Inamdar SM, Thomas CP, Goel A, Choudhury A. Secretion of soluble vascular endothelial growth factor receptor 1 (sVEGFR1/sFlt1) requires Arf1, Arf6, and Rab11 GTPases. Plos One. 7: e44572. PMID 22962618 DOI: 10.1371/Journal.Pone.0044572 |
0.309 |
|
2012 |
Brown CO, Salem K, Wagner BA, Bera S, Singh N, Tiwari A, Choudhury A, Buettner GR, Goel A. Interleukin-6 counteracts therapy-induced cellular oxidative stress in multiple myeloma by up-regulating manganese superoxide dismutase. The Biochemical Journal. 444: 515-27. PMID 22471522 DOI: 10.1042/Bj20112019 |
0.655 |
|
2012 |
Goel A, Spitz DR, Weiner GJ. Manipulation of cellular redox parameters for improving therapeutic responses in B-cell lymphoma and multiple myeloma. Journal of Cellular Biochemistry. 113: 419-25. PMID 21956712 DOI: 10.1002/Jcb.23387 |
0.454 |
|
2012 |
Goel A. Combination Therapy for Multiple Myeloma: How Far Have We Come? Journal of Developing Drugs. 1. DOI: 10.4172/2329-6631.1000E113 |
0.394 |
|
2012 |
Salem K, Brown CO, Schibler J, Goel A. Differential Regulation of Nuclear Factor (NF)-?B Activity Overcomes Therapy Resistance in Human Multiple Myeloma Cells Free Radical Biology and Medicine. 53: S43. DOI: 10.1016/J.Freeradbiomed.2012.10.111 |
0.628 |
|
2011 |
Salem K, Brown CO, Salem K, Bera S, Tiwari A, Choudhury A, Goel A. IL-6 mediated upregulation of glutathione and manganese superoxide dismutase inhibits therapy-induced cellular oxidative stress in multiple myeloma Free Radical Biology and Medicine. 51: S129. DOI: 10.1016/J.Freeradbiomed.2011.10.338 |
0.625 |
|
2011 |
Fletcher EV, Sobhakumari A, Brown CO, Case AJ, Spitz DR, Domann FE, Goel A, Simons AL. EGFR Inhibition Induces IL6 Expression Via NOX4 in Head and Neck Cancer Cells Free Radical Biology and Medicine. 51: S133-S134. DOI: 10.1016/J.Freeradbiomed.2011.10.278 |
0.339 |
|
2010 |
Bera S, Greiner S, Choudhury A, Dispenzieri A, Spitz DR, Russell SJ, Goel A. Dexamethasone-induced oxidative stress enhances myeloma cell radiosensitization while sparing normal bone marrow hematopoiesis. Neoplasia (New York, N.Y.). 12: 980-92. PMID 21170263 DOI: 10.1593/Neo.101146 |
0.453 |
|
2010 |
Bera S, Brown C, Rivera LC, Goel A. IL6 Mediated Upregulation of MnSOD Protects Multiple Myeloma Cells Against Ionizing Radiation Induced Cell Death Free Radical Biology and Medicine. 49: S55. DOI: 10.1016/J.Freeradbiomed.2010.10.124 |
0.399 |
|
2007 |
Goel A, Carlson SK, Classic KL, Greiner S, Naik S, Power AT, Bell JC, Russell SJ. Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Delta51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene. Blood. 110: 2342-50. PMID 17515401 DOI: 10.1182/Blood-2007-01-065573 |
0.325 |
|
2006 |
Goel A, Dispenzieri A, Geyer SM, Greiner S, Peng KW, Russell SJ. Synergistic activity of the proteasome inhibitor PS-341 with non-myeloablative 153-Sm-EDTMP skeletally targeted radiotherapy in an orthotopic model of multiple myeloma Blood. 107: 4063-4070. PMID 16424391 DOI: 10.1182/Blood-2005-09-3870 |
0.364 |
|
2006 |
Greipp PT, Collins DA, Russell SJ, Harvey ME, Goel A, Greipp PR. In-111DAC Is a Novel Technique To Image Multiple Myeloma. Blood. 108: 3488-3488. DOI: 10.1182/Blood.V108.11.3488.3488 |
0.304 |
|
2006 |
Goel A, Dispenzieri A, Witzig TE, Russell SJ. Enhancing the therapeutic index of radiation in multiple myeloma Drug Discovery Today: Disease Mechanisms. 3: 515-522. DOI: 10.1016/J.Ddmec.2006.11.012 |
0.371 |
|
2005 |
Goel A, Dispenzieri A, Greipp PR, Witzig TE, Mesa RA, Russell SJ. PS-341-mediated selective targeting of multiple myeloma cells by synergistic increase in ionizing radiation-induced apoptosis. Experimental Hematology. 33: 784-95. PMID 15963854 DOI: 10.1016/J.Exphem.2005.04.005 |
0.439 |
|
2005 |
Goel A, Dispenzieri A, Geyer SM, Greiner S, Russell SJ. Synergistic Activity of the Proteasome Inhibitor PS-341 with Non-Myeloablative 153-Sm-EDTMP in a Syngeneic, Orthotopic Model of Multiple Myeloma. Blood. 106: 3453-3453. DOI: 10.1182/Blood.V106.11.3453.3453 |
0.401 |
|
2004 |
Goel A, Dispenzieri A, Greipp PR, Witzig TE, Mesa RA, Russell SJ. PS-341 Induces Selective Radiosensitization of Multiple Myeloma Cells. Blood. 104: 2478-2478. DOI: 10.1182/Blood.V104.11.2478.2478 |
0.43 |
|
2001 |
Wittel UA, Goel A, Varshney GC, Batra SK. Mucin antibodies - new tools in diagnosis and therapy of cancer Frontiers in Bioscience : a Journal and Virtual Library. 6. PMID 11578978 DOI: 10.2741/Wittel |
0.321 |
|
2001 |
Goel A, Batra SK. Antibody constructs for radioimmunodiagnosis and treatment of human pancreatic cancer. Teratogenesis, Carcinogenesis, and Mutagenesis. 21: 45-57. PMID 11135320 DOI: 10.1002/1520-6866(2001)21:1<45::Aid-Tcm5>3.0.Co;2-A |
0.356 |
|
2000 |
Goel A, Beresford GW, Colcher D, Pavlinkova G, Booth BJ, Baranowska-Kortylewicz J, Batra SK. Divalent forms of CC49 single-chain antibody constructs in Pichia pastoris: expression, purification, and characterization. Journal of Biochemistry. 127: 829-36. PMID 10788792 DOI: 10.1093/Oxfordjournals.Jbchem.A022676 |
0.3 |
|
Show low-probability matches. |